338 results
Page 3 of 17
8-K
EX-4.1
j2qlfmpsh024ei92gka
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-1.1
vni6ud38ep1qgmx aj
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-4.2
1rvrse4tkoun j8qrwls
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
S-8
EX-4.4
2qs6fguc8uyn6465z
12 Feb 21
Registration of securities for employees
4:23pm
8-K
EX-10.1
nurfpvyqlhm
31 Dec 20
Departure of Directors or Certain Officers
4:16pm
DEF 14C
0fi33540tb535m9tuu
29 Dec 20
Information statement
4:59pm
8-K
EX-10.1
34x5ubbu
23 Jul 20
Departure of Directors or Certain Officers
4:55pm
8-K
EX-4.1
62hjrdj 38p2vaxt
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-4.2
zcbb54cqy4
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
bp8 yitjr
21 May 20
Prospectus supplement with pricing info
6:04am
8-K
EX-99.1
24kztzzmuvd
14 May 20
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
8:12am